Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease

NCT00524355 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00524355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2007
Completion date
November 30, 2007
Enrollment
2,717 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gerd